# Selected Large-Animal Models of Ventricular Arrhythmias

**Authors:** Piotr Frydrychowski, Alicja Cepiel-Kośmieja, Zuzanna Wojtczak, Krzysztof Nowak, Agnieszka Noszczyk-Nowak

PMC · DOI: 10.3390/biology15040343 · Biology · 2026-02-15

## TL;DR

This paper reviews large-animal models used to study dangerous heart rhythm disorders, highlighting their importance for understanding and treating these conditions in humans.

## Contribution

The paper provides a focused synthesis of selected large-animal models and their methodological approaches for ventricular arrhythmia research.

## Key findings

- Porcine models are considered the most translationally relevant due to their anatomical and electrophysiological similarity to human hearts.
- Canine models have contributed significantly but are limited by ethical and regulatory concerns.
- Large-animal models are essential for preclinical testing of new therapies and devices.

## Abstract

Ventricular arrhythmias represent a leading cause of sudden cardiac death and remain a critical challenge in cardiovascular medicine. Their multifactorial mechanisms and substantial fatality risk continue to drive intensive research focused on clarifying arrhythmogenic pathways and optimizing preventive and therapeutic approaches. Large-animal models are central to this effort because they more faithfully reflect human cardiac structure and electrophysiological properties than small-animal systems. Species most frequently used in this field include dogs, cats, pigs, sheep, and goats. Although canine models have contributed extensively to mechanistic and translational insights, their contemporary use is increasingly limited by regulatory constraints and ethical considerations. Ovine and caprine models, while less prevalent, provide complementary information and have supported progress in selected applications. Among available large-animal platforms, porcine models are widely considered the most translationally relevant, given the close anatomical and electrophysiological correspondence between pig and human hearts and the practicality of reproducibly inducing ventricular arrhythmias, particularly in acute ischemia following coronary occlusion. Importantly, large-animal studies remain indispensable for the preclinical assessment of emerging pharmacotherapies, interventional strategies, and medical devices prior to evaluation in humans. This article synthesizes representative studies using large-animal ventricular arrhythmia models, with a focus on reported materials and methodological approaches.

Ventricular arrhythmias are among the most life-threatening cardiac rhythm disturbances. Owing to their complex pathophysiology and high mortality risk, they remain a major focus of research aimed at elucidating underlying mechanisms and improving prevention and therapeutic strategies. In this context, animal models—particularly large-animal models—are of pivotal importance because they more closely recapitulate human cardiac anatomy and electrophysiology. The most commonly used species include dogs, cats, pigs, sheep and goats. Dogs have historically played a prominent role in ventricular arrhythmia research; however, their use is increasingly constrained by legal regulations and ethical–societal considerations. Sheep and goats, although employed less frequently, have also contributed meaningfully to advances in the field. Among large-animal models, swine are regarded as especially promising, largely due to the similarity between porcine and human hearts and the feasibility of reliably inducing ventricular arrhythmias, particularly under conditions of acute ischemia associated with coronary artery occlusion. Large-animal models are also indispensable for the preclinical evaluation of novel drugs, therapeutic approaches, and medical devices prior to translation into human studies. In this article, we review selected investigations employing large-animal models of ventricular arrhythmias, with particular emphasis on the materials and methods reported in the cited literature.

## Full-text entities

- **Genes:** RYR2 (ryanodine receptor 2) [NCBI Gene 403615], STRN (striatin) [NCBI Gene 100683096], FKBP1B (FKBP prolyl isomerase 1B) [NCBI Gene 612965], KCNA5 (potassium voltage-gated channel subfamily A member 5) [NCBI Gene 403995] {aka Kv1.5}, CD68 [NCBI Gene 489476], ADRB1 (adrenoceptor beta 1) [NCBI Gene 493972], PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 490255] {aka CD45}, TRPV1 (transient receptor potential cation channel subfamily V member 1) [NCBI Gene 445457] {aka VR1}
- **Diseases:** LV remodeling (MESH:D018487), sustained tachycardia (MESH:D013610), fatty infiltration (MESH:D017254), hypoxic (MESH:D002534), Ischemic Ventricular Arrhythmias (MESH:D001145), structural (MESH:D020914), myocardial injury (MESH:D009202), hypercapnia (MESH:D006935), SCD (MESH:D016757), myocarditis (MESH:D009205), PVC (MESH:D018879), stenosis (MESH:D003251), ischemia (MESH:D007511), arrhythmic (OMIM:212500), GSDs (MESH:C562543), parasympathetic (MESH:D001342), vomiting (MESH:D014839), Bradycardia (MESH:D001919), respiratory acidosis (MESH:D000142), LCA (MESH:C536600), fatty replacement (MESH:D008067), inflammation (MESH:D007249), injury to (MESH:D014947), desmosomal disease (MESH:D004194), VA (MESH:C563443), sinus bradycardia hypoactivity (MESH:D012804), syncope (MESH:D013575), fibrosis (MESH:D005355), myocardial remodeling (MESH:D064752), malignant (MESH:D009369), poisoning (MESH:D011041), Ischemic (MESH:D002545), right bundle branch block (MESH:D002037), cardiac arrest (MESH:D006323), TdP (MESH:D016171), ARVC (MESH:D019571), calcium (MESH:D002128), infarct (MESH:D007238), atrial dilation (MESH:C563984), congestive heart failure (MESH:D006333), fibrofatty remodeling (MESH:D020257), anterior myocardial infarction (MESH:D056988), ventricular enlargement (MESH:D006332), Goats (MESH:D015511), dysfunction of the heart (MESH:D006331), coronary arteries (MESH:D003324), VF (MESH:D014693), QT interval prolongation (MESH:D008133), NSVT (MESH:D017180), EAD (MESH:C566415), PVS (MESH:D018458), reperfusion injury (MESH:D015427), Mortality (MESH:D003643), descending artery (MESH:D000094627), LAD occlusion (MESH:D001157), balloon occlusion (MESH:D054549), GSD arrhythmias (MESH:D016098), ventricular ectopy (MESH:D050030), DCM (MESH:D002311), artery (MESH:D012078)
- **Chemicals:** water (MESH:D014867), GABA (MESH:D005680), norepinephrine (MESH:D009638), HCl (MESH:D006851), NE (MESH:D009356), alkaloid (MESH:D000470), polyethylene (MESH:D020959), volatile organic compounds (MESH:D055549), cAMP (MESH:D000242), RTX (MESH:C024353), bucindolol (MESH:C024307), oxygen (MESH:D010100), cesium chloride (MESH:C028019), Epinephrine (MESH:D004837), isoprenaline (MESH:D007545), digitalis glycoside (MESH:D004071), bupivacaine (MESH:D002045), polystyrene (MESH:D011137), Aconitine (MESH:D000157), carbon dioxide (MESH:D002245), ouabain (MESH:D010042), lipid (MESH:D008055), nitrous oxide (MESH:D009609), metoclopramide (MESH:D008787), ether (MESH:D004986), calcium (MESH:D002118), Ca2+ (-), H&amp;E (MESH:D006371), halothane (MESH:D006221), cyclopropane (MESH:C030797), lidocaine (MESH:D008012), potassium (MESH:D011188), sodium (MESH:D012964), catecholamines (MESH:D002395), MgSO4 (MESH:D008278), sotalol (MESH:D013015), quinidine (MESH:D011802)
- **Species:** Ovis aries (domestic sheep, species) [taxon 9940], Sus scrofa (pig, species) [taxon 9823], Mus musculus (house mouse, species) [taxon 10090], Canis lupus familiaris (dog, subspecies) [taxon 9615], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Equus caballus (domestic horse, species) [taxon 9796], Capra hircus (domestic goat, species) [taxon 9925], Homo sapiens (human, species) [taxon 9606], Felis catus (cat, species) [taxon 9685]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938540/full.md

## References

94 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938540/full.md

---
Source: https://tomesphere.com/paper/PMC12938540